Universitat Internacional de Catalunya

Drug Delivery & Discovery

Drug Delivery & Discovery
6
13553
3
Second semester
op
ELECTIVE
ELECTIVE
Main language of instruction: English

Other languages of instruction: Catalan, Spanish,

Teaching staff


Please send an email to set up a meeting

Alba Herrero: aherrerog@uic.es

Samantha Morón: smoron@uic.es

José Muñoz: jmunozl@uic.es

Introduction

The Drug Delivery & Discovery course focuses on the search for new strategies for drug administration, the validation methods, and the possible outcomes in drug development. By using vehicles designed for an easier and adequate release, their therapeutic action can be much more effective and efficient compared to other traditional drug delivery methods. Following the drug development process, we will have a first block focused on drug discovery, the understanding of the different drug administration routes and vehicles used in both clinical and preclinical stages. During the second block of this class, we will review the processes, regulations, specific studies, and validation steps needed to release a drug in the market. With a focus on the creation of preclinical and clinical trials, we will study the many steps involved in these processes and the techniques used to regulate this high-risk high-reward race to help patients worldwide.

Pre-course requirements

The student must have successfully passed the Cellular and Molecular Biology (1st semester) and Biomaterials and Biocompatibility subject (2nd semester).  It is recommended to have knowledge of Pharmacology (5th semester)

Objectives

  • Explain to the student the knowledge of the process of discovery of new drugs and targets.
  • That the student has the basic knowledge of the different types of drug administration routes, as well as the drug properties and methods of action.
  • That the student understands the different steps involved in the preclinical and clinical phases.
  • That the student has a first contact with the necessary tools for the discovery of new drugs and presentation of practical cases through a poster presentation

Competences/Learning outcomes of the degree programme

  • CB1 - Students must demonstrate that they have and understand knowledge in an area of study based on general secondary education. This knowledge should be of a level that, although based on advanced textbooks, also includes some of the cutting-edge elements from their field of study.
  • CB2 - Students must know how to apply their knowledge to their work or vocation in a professional way and have the competences that are demonstrated through the creation and defence of arguments and the resolution of problems within their field of study.
  • CB3 - Students must have the ability to bring together and interpret significant data (normally within their area of study) and to issue judgements that include a reflection on important issues that are social, scientific or ethical in nature.
  • CB4 - Students can transmit information, ideas, problems and solutions to specialist and non-specialist audiences.
  • CB5 - Students have developed the necessary learning skills to undertake subsequent studies with a high degree of autonomy.
  • CE16 - To apply specific Bioengineering terminology both verbally and in writing in a foreign language.
  • CE17 - To be able to identify the engineering concepts that can be applied in the fields of biology and health.
  • CE19 - To know how to select and apply material based on its properties and electric, magnetic, mechanical and chemical behaviour
  • CE21 - The ability to understand and apply biotechnological methodologies and tools to research, as well as to the development and production of products and services.
  • CE8 - To hold a dialogue based on critical thinking on ideas connected to the main dimensions of the human being
  • CG10 - To know how to work in a multilingual and multidisciplinary environment.
  • CG2 - To promote the values that are specific to a peaceful culture, thus contributing to democratic coexistence, respect for human rights and fundamental principles such as equality and non-discrimination.
  • CG3 - To be able to learn new methods and theories and be versatile so as to adapt to new situations.
  • CG4 - To resolve problems based on initiative, be good at decision-making, creativity, critical reasoning and communication, as well as the transmission of knowledge, skills and prowess in the field of Bioengineering
  • CG7 - To analyse and evaluate the social and environmental impact of technical solutions
  • CG8 - To apply quality principles and methods.
  • CT1 - To understand company organisation and the science that governs its activities; to apply work-related rules and understand the relationship between planning, industrial and commercial strategies, quality and profit.
  • CT3 - To know how to communicate learning results to other people both verbally and in writing, and well as thought processes and decision-making; to participate in debates in each particular specialist areas.
  • CT5 - To use information sources in a reliable manner. To manage the acquisition, structuring, analysis and visualisation of data and information in your specialist area and critically evaluate the results of this management.
  • CT6 - To detect gaps in your own knowledge and overcome this through critical reflection and choosing better actions to broaden your knowledge.
  • CT7 - To be fluent in a third language, usually English, with a suitable verbal and written level that is in line with graduate requirements.

Learning outcomes of the subject

  • Knowledge of the drug development process.
  • Knowledge of the main drugs, forms of administration and release and their action properties.
  • Knowledge of the preclinical and clinical stages, their main differences and occupations within.
  • Be able to understand and use the tools for drug design.
  • Be able to work on a related topic, display it on a poster and know how to defend it

Syllabus

  1. Principles of drug discovery and drug development
  2. Pharmacokinetics and pharmacodynamics
  3. Drug administration routes
  4. Drug encapsulation and release strategies
  5. Preclinical trials
  6. Clinical trials
  7. Medical devices

Teaching and learning activities

In person



The course will be divided into theoretical classes and practical cases for the design of drugs and the development of a poster, which students will learn how to define, design and present to defend it. In some cases, evaluable activities may be carried out during the sessions that cannot be recovered outside of that period.

Eventually, the teacher could use the Moodle platform that could include various resources, such as forms, exercises, multimedia material ... that the student must perform to complete the subject. 

Els treballs lliurats fora de temps només podran obtenir una màxima qualificació de 5 punts sobre 10, excepte aquells que només podran realitzar-se durant la sessió.

Classes will be taught in English. The teaching material will be presented mainly in English, with some exceptions (graphs, tables ...)

The list of ECTS credits and the workload in learning hours depending on the different methodologies that will be used. Each ECTS theoretical credit has 10 hours in which the teacher has a presence in the classroom. The rest of the hours up to 25 correspond to the load of directed and autonomous learning of the student. This last teaching load can be done through autonomous activities, group work that will be presented and defended in class or individual study necessary to achieve the learning objectives of the different subjects.

Evaluation systems and criteria

In person



First call exam:

  1. Midterm exam (30%)
  2. Assignments and projects (25%)
  3. Poster project (15%)
  4. Final exam (30%)

 

A minimal mark of 5.0 should be obtained in the final exam and midterm in order to be taken for the calculation of the course average. The same evaluation criteria will be applied in the second sitting of the exam, without the possibility of obtaining a distinction with honors. In case of failure of the midterm exam, the student will have an extra exam the same day of the final exam.

Attendance is mandatory for all projects to pass the course.

Assignments will not be accepted after the deadline and will only be accepted by Moodle and not by email, with the exception of the in-class problems/projects that only will be allowed during the session.

 

Important considerations

  1. Plagiarism, copying or any other action that may be considered cheating will be zero in that evaluation section. Besides, in exams it will mean the immediate failure of the whole subject.
  2. In the second-sitting exams, the maximum grade students will be able to obtain is "Excellent" (grade with honors distinction will not be possible).
  3. Changes of the calendar, exam dates or the evaluation system will not be accepted.
  4. Exchange students (Erasmus and others) or repeaters will be subjected to the same conditions as the rest of the students.

Bibliography and resources

  1. Hillery AM, Park K. (2016) Drug Delivery Systems. 2nd ed. CRC Press. https://www.crcpress.com/Drug-Delivery-Fundamentals-and-Applications-Second-Edition/Hillery-Park/p/book/9781482217711.
  2. G Hill, R., & Richards, D. (2021). Drug Discovery and Development (3rd ed.). Elsevier. https://www.mea.elsevierhealth.com/drug-discovery-and-development-9780702078040.html

Evaluation period

E: exam date | R: revision date | 1: first session | 2: second session:
  • E1 30/05/2024 P2A03 14:00h
  • E2 27/06/2024 P2A02 10:00h